Business Context and Reporting Period
This Form 8-K was filed by Akari Therapeutics Plc (formerly Celsus Therapeutics Plc) on December 24, 2015, reporting events occurring on December 18, 2015. The Company is incorporated in England and Wales and operates in the biotechnology sector.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance regarding the independent registered public accounting firm.
Material Changes
The primary material change reported is the replacement of the Company's independent auditor:
- Outgoing Auditor: Kost, Forer, Gabbay & Kasierer (a member of Ernst & Young Global) was dismissed effective December 18, 2015.
- Incoming Auditor: BDO AG was engaged as the independent registered public accounting firm for the fiscal year ending December 31, 2015.
- Audit History: Reports for the fiscal years ended December 31, 2013, and December 31, 2014, did not contain adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
- Disagreements: There were no disagreements with the outgoing auditor on accounting principles, financial statement disclosures, or auditing scope during the two most recent fiscal years or the interim period through December 18, 2015.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors beyond the standard disclosure of the auditor change. The Company confirmed that the outgoing auditor agreed with the statements regarding the lack of disagreements, as evidenced by a letter dated December 24, 2015, filed as Exhibit 16.1.
Investor Verification Checklist
- Verify the reasons for the auditor change by reviewing the letter from Kost, Forer, Gabbay & Kasierer (Exhibit 16.1).
- Confirm the transition timeline and any potential impact on the audit of the fiscal year ending December 31, 2015.
- Review subsequent filings (e.g., 10-K) to ensure the new auditor, BDO AG, has completed the audit without qualification.